Sustained high levels of circulatory interleukin-8 are associated with a poor outcome in patients with adult respiratory distress syndrome

Internal Medicine

Volumn 35, Issue 11, 1996, Pages 855-860

  Ikuta, Nobuya ^a   Taniguchi, Hiroyuki ^a   Kondoh, Yasuhiro ^a   Takagi, Kenzo ^b   Hayakawa, Tetsuo ^b  

^a TOSEI GENERAL HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute lung injury; Interleukin 8; Neutrophil elastase; Outcome predictors

Indexed keywords

INTERLEUKIN 8; LEUKOCYTE ELASTASE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; BLOOD; ENZYMOLOGY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; NEUTROPHIL; PROGNOSIS; SURVIVOR;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INTERLEUKIN-8; LEUKOCYTE ELASTASE; MALE; MIDDLE AGED; NEUTROPHILS; PROGNOSIS; RESPIRATORY DISTRESS SYNDROME, ADULT; SURVIVORS;

EID: 0030277022     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.35.855     Document Type: Article

References (30)

1. Sibille Y, Reynolds HY. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 141: 471, 1990.
2. Idell S, Kucich U, Fein A, et al. Neutrophil elastase-releasing factors in bronchoalveolar lavage from patients with adult respiratory distress syndrome. Am Rev Respir Dis 132: 1098, 1985.
3. Weiland JE, Davis WB, Holter JF, Mohammed JR, Dorinsky PM, Gadek JE. Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance. Am Rev Respir Dis 133: 218, 1986.
4. Fowler AA, Hyers TM, Fisher BJ, Bechard DE, Centor RM, Webster RO. The adult respiratory distress syndrome. Cell populations and soluble mediators in the air spaces of patients at high risk. Am Rev Respir Dis 136: 1225, 1987.
5. Baggiolini M, Walz A, Kunkel SL. Neutrophil activating peptide-1/ interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84: 1045, 1989.
6. Colditz I, Zwahlen R, Dewald B, Baggiolini M. In vivo inflammatory activity of neutrophil-activating factor, a novel chemotactic peptide derived from human monocytes. Am J Pathol 134: 755, 1989.
7. Peveri P, Walz, A, Dewald B, Baggiolini M. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J Exp Med 167: 1547, 1988.
8. Schröder JM, Mrowietz U, Morita E, Christophers E. Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity. J Immunol 139: 3474, 1987.
9. Miller EJ, Cohen AB, Nagao S, et al. Elevated levels of NAP-1/inlerleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis 146: 427, 1992.
10. Donnelly SC, Strieter RM, Kunkel SL, et al. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patients groups. Lancet 341: 643, 1993.
11. Chollet-Martin S, Montravers P, Gibert C, et al. High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome. Infect Immun 61: 4553, 1993.
12. Hoch RC, Rodriguez R, Manning T, et al. Effects of accidental trauma on cytokine and endotoxin production. Crit Care Med 21: 839, 1993.
13. Roumen RMH, Hendriks T, van der Ven-Jongekrijg J, et al. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg 218: 769, 1993.
14. Burkhardt A. Alveolitis and collapse in the pathogenesis of pulmonary fibrosis. Am Rev Respir Dis 140: 513, 1989.
15. Fowler AA, Hamman RF, Good JT, et al. Adult respiratory distress syndrome: risk with common predispositions. Ann Intern Med 98: 593, 1983.
16. Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 138: 720, 1988.
17. Ida N, Sakurai S, Hosoi K, KunitomoT. A highly sensitive enzyme-linked immunosorbent assay for the measurement of interleukin-8 in biological fluids. J Immunol Methods 156: 27, 1992.
18. Hack CE, Hart M, van Schijndel RJM, et al. Interleukin-8 in sepsis: Relation to shock and inflammatory mediators. Infect Immun 60: 2835, 1992.
19. Lynch III JP, Standiford TJ, Rolfe MW, Kunkel SL, Strieter RM. Neutrophilic alveolitis in idiopathic pulmonary fibrosis: the role of interleukin-8. Am Rev Respir Dis 145: 1433, 1992.
20. Rocker GM, Wiseman MS, Pearson D, Shale DJ. Diagnostic criteria for adult respiratory distress syndrome: time for reappraisal. Lancet 1: 120, 1989.
21. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 2: 319, 1967.
22. Montgomery AB, Stager MA, Carrico CJ, Hudson LD. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 132: 485, 1985.
23. 1 Study Group. Adult respiratory distress syndrome. Sequence and importance of development of multiple organ failure. Chest 101: 320, 1992.
24. Knaus WA, Sun X, Hakim RB, Wagner DP. Evaluation of definitions for adult respiratory distress syndrome. Am J Respir Crit Care Med 150: 311, 1994.
25. Meduri GU, Headley S, Kohler G, et al. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1β and IL-6 levels are consistent and efficient predictors of outcome overtime. Chest 107: 1062, 1995.
26. Baldwin SR, Simon RH, Grum CM, Ketai LH, Boxer LA, Devall LJ. Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet 1: 11, 1986.
27. Bazzoni F, Cassatella MA, Rossi F, Ceska M, Dewald B, Baggiolini M. Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8. J Exp Med 173: 771, 1991.
28. Cassatella MA, Bazzoni F, Ceska M, Ferro I, Baggiolini M, Berton G. IL-8 production by human polymorphonuclear leukocytes. The chemoattractant formyl-methionyl-leucyl-phenylalanine induces the gene expression and release of IL-8 through a pertussis toxin-sensitive pathway. J Immunol 148: 3216, 1992.
29. DeForge LE, Kenney JS, Jones ML, Warren JS, Remick DG. Biphasic production of IL-8 in lipopolysaccharide(LPS)-stimulated human whole blood. Separation of LPS- and cytokine-stimulated components using anti-tumor necrosis factor and anti-IL-1 antibodies. J Immunol 148: 2133, 1992.
30. Hudson LD. New therapies for ARDS. Chest 108: 79S, 1995.